✦ LIBER ✦

Clinical Implications of KRAS Mutations in Lung Cancer Patients Treated with Tyrosine Kinase Inhibitors: An Important Role for Mutations in Minor Clones

✍ Scribed by Marchetti, Antonio; Milella, Michele; Felicioni, Lara; Cappuzzo, Federico; Irtelli, Luciana; Del Grammastro, Maela; Sciarrotta, Mariagrazia; Malatesta, Sara; Nuzzo, Carmen; Finocchiaro, Giovanna; Perrucci, Bruno; Carlone, Donatella; Gelibter, Alain J.; Ceribelli, Anna; Mezzetti, Andrea; Iacobelli, Stefano; Cognetti, Francesco; Buttitta, Fiamma

Book ID: 122163812
Publisher: Neoplasia Press
Year: 2009
Tongue: English
Weight: 453 KB
Volume: 11
Category: Article
ISSN: 1522-8002
DOI: 10.1593/neo.09814

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

KRAS Mutation Is an Important Predictor

KRAS Mutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer

✍ Massarelli, E.; Varella-Garcia, M.; Tang, X.; Xavier, A. C.; Ozburn, N. C.; Liu, 📂 Article 📅 2007 🏛 American Association for Cancer Research 🌐 English ⚖ 196 KB

Do We Really Need Another Epidermal Grow

Do We Really Need Another Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in First-Line Treatment for Patients With Non-Small-Cell Lung Cancer and EGFR Mutations?

✍ Haspinger, E. R.; Garassino, M. C.; Torri, V.; Cinquini, M.; De Braud, F.; Gelso 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 78 KB

Different treatment orders achieved simi

Different treatment orders achieved similar clinical results: a retrospective study for retreatment of epidermal growth factor receptor tyrosine kinase inhibitors in 120 patients with non-small-cell lung cancer

✍ Tang, Chuanhao; Gao, Hongjun; Li, Xiaoyan; Liu, Yi; Li, Jianjie; Qin, Haifeng; W 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 350 KB